Israel Archives

News and Trends 31 Jul 2018

Israeli Crohn’s Disease Drug Rakes in Positive Phase III Results

RedHill Biopharma has obtained positive Phase III results for its Crohn’s disease treatment, which targets a certain type of gut bacteria. Crohn’s disease is a type of inflammatory bowel disease, characterized by acute flare-ups and periods of symptom-free remission, that can affect any part of the gastrointestinal tract. It has a high prevalence for an autoimmune disease, […]

July 31, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 11 Jul 2018

Radioactive Nanoparticle Could Improve Cancer Diagnoses

Isotopia Molecular Imaging, an Israeli company, is developing a radioactive marker made of gold nanoparticles to detect cancer more accurately than with current diagnostic tools. PET and CT scans are two types of X-ray tests that use small quantities of radioactive materials, called contrast agents, to help visualize and assess organ and tissue function. These […]

July 11, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 19 Jun 2018

Biomaterial to Regenerate Teeth Approved in Europe

The Israeli company Datum Dental has received approval to launch a biomaterial for dental implants in Europe and Canada. Datum Dental has developed a biomaterial specifically designed to help the body regenerate real bone tissue after dental operations. Launched in the US last year, the biomaterial has now received CE marking in Europe and approval […]

June 19, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Startup Scout 15 Jun 2018

This Israeli Biotech is Making Cultured Meat More Like the Real Thing

Today, we’re in Ashdod, Israel, visiting Aleph Farms, a biotech that’s making cultured meat grown in a 3D environment that resembles the texture of natural meat. Mission: Founded in 2017, Aleph Farms uses cell samples taken from living cattle to create cultured meat. The cells are then grown in a 3D environment, which can help […]

June 15, 2018 - 2 minutesmins - By Alexander Burik

pluristem cell therapy peripheral artery disease

News and Trends 13 Jun 2018

Placenta Cell Therapy Improves Mobility in Patients with Peripheral Artery Disease

The Israeli biotech Pluristem has Phase II data indicating that its cell therapy made of placenta cells can help patients suffering from peripheral artery disease recover their mobility. The trial, run in the US, Germany, South Korea and Israel, enrolled 172 patients with intermittent claudication, an early stage of peripheral artery disease where the legs […]

June 13, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Startup Scout 8 Jun 2018

This Israeli Biotech Engineers Tobacco Plants to Make Collagen

This week we’re in Ness Ziona, Israel, visiting CollPlant, a biotech that engineers tobacco plants to produce collagen for a variety of uses, including 3D printing and artificial tendons. Mission: CollPlant engineers tobacco plants to express five human genes, which enables the plants to produce recombinant human collagen. The material can be used in different […]

June 8, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 26 Apr 2018

Israeli Cell Therapy for Muscle Injury Will Start Phase III Trial in US

Pluristem Therapeutics will start a Phase III trial this year in the US for its pioneering cell therapy that uses placenta cells to restore muscle injuries. Pluristem Therapeutics, an Israeli biotech and world-leader in cell therapies, has received a green light from the FDA to start a Phase III study in the US. The trial will test […]

April 26, 2018 - 2 minutesmins - By Alexander Burik

Startup Scout 13 Apr 2018

This Israeli Biotech Targets Protein Translation to Fight Disease

Today, we’re taking a look at Anima Biotech, an Israeli company that is developing a new class of drugs that target protein translation to combat a range of diseases, including lung fibrosis, cancer, and Huntington’s disease. Mission: Since 2010, Anima Biotech has been targeting disease-causing proteins with a new class of drugs that control protein translation. […]

April 13, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 20 Dec 2017

Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease

BiomX has acquired RondinX, expanding its bacterial target discovery platform and adding new microbiome targets for chronic liver disease. BiomX is a company based in Ness Ziona, Israel, developing customized phage therapy to selectively destroy the bacteria that cause diseases ranging from inflammatory bowel disease (IBD) to cancer. The company has just acquired RondinX, another […]

December 20, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 5 Dec 2017

PayPal Co-Founder Backs Israeli Biotech Attacking NASH with an Antibody

ChemomAb kicked off its antibody efforts as a company in 2011, and its $10M Series B has attracted none other than Peter Thiel. Israeli biotech has been attracting quite sizeable funds recently, largely those of UK investment outfit Arix Bioscience. Yesterday it was announced that Peter Theil, co-founder of PayPal and assassin of Gawker, led […]

December 5, 2017 - 2 minutesmins - By Evelyn Warner

News and Trends 4 Dec 2017

Israeli Biotech Gets $30M Backing for its Immune Modulators for Severe Infections

Atox Bio develops immune modulators to save patients with severe infections. An oversubscribed Series F financing will support its lead candidate through a Phase II trial. Atox Bio, which has operations in the US and Israel, develops immune modulators for patients with severe infections. The biotech was established at the Hebrew University of Jerusalem and Yissum. […]

December 4, 2017 - 2 minutesmins - By Alex Dale

More News! 17 Jul 2017

Israeli Biotech Partners with German Chem Giant to Develop Non-GMO Herbicide Resistance

Kaiima and BASF have partnered to develop crops with new herbicide resistance traits using non-GMO genetic engineering technology. Kaiima Bio Agritech works on boosting crop performance by using the plant’s own DNA, without the need of introducing external genes. In order to leverage this technology, the company has partnered with the giant chemical company BASF to discover […]

July 17, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Resources

Categories

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Israel

Israeli Crohn’s Disease Drug Rakes in Positive Phase III Results

Radioactive Nanoparticle Could Improve Cancer Diagnoses

Biomaterial to Regenerate Teeth Approved in Europe

This Israeli Biotech is Making Cultured Meat More Like the Real Thing

Placenta Cell Therapy Improves Mobility in Patients with Peripheral Artery Disease

This Israeli Biotech Engineers Tobacco Plants to Make Collagen

Israeli Cell Therapy for Muscle Injury Will Start Phase III Trial in US

This Israeli Biotech Targets Protein Translation to Fight Disease

Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease

PayPal Co-Founder Backs Israeli Biotech Attacking NASH with an Antibody

Israeli Biotech Gets $30M Backing for its Immune Modulators for Severe Infections

Israeli Biotech Partners with German Chem Giant to Develop Non-GMO Herbicide Resistance

Subscribe to our newsletter to get the latest biotech news!

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!